Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2025 00:00 ET | Source: Sernova Biotherapeutics, Inc.

Chair of Sernova Biotherapeutics Resigns

LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...
May 22, 2025 07:00 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

LONDON, Ontario and BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...
May 14, 2025 07:00 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

Clinical Study on Track to Meet its Primary and Secondary Endpoints Data Demonstrate That Metabolic Measures Improve with Cumulative Quantities of Transplanted Donor Islets Data Demonstrate Islet...
April 22, 2025 08:37 ET | Source: Sinovac Holding Group Co., Ltd.

科兴控股生物技术有限公司管理层关于审计师辞职的声明

北京, April 22, 2025 (GLOBE NEWSWIRE) -- 致科兴控股生物技术有限公司全体股东及各利益相关方：科兴控股生物技术有限公司（纳斯达克股票代码：SVA，以下简称 “公司”）的管理层近日收到公司外部审计师的通知，审计师已决定辞去公司2024 财年年终审计师职务。 ...
April 22, 2025 00:06 ET | Source: Sinovac Holding Group Co., Ltd.

SINOVAC Management Statement Regarding Auditor Resignation

Beijing, April 22, 2025 (GLOBE NEWSWIRE) -- To the Shareholders of Sinovac Biotech Ltd. and Other Stakeholders: The management of Sinovac Biotech Ltd. (NASDAQ: SVA, “SINOVAC” or the “Company”)...
April 17, 2025 08:00 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s...
April 15, 2025 16:05 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the...
April 01, 2025 08:00 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

DSMB supports advancement for Sernova’s clinical trial Study is on track to meet key clinical trial endpoints LONDON, Ontario and BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Sernova...
March 10, 2025 08:00 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D

LONDON, Ontario and BOSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s...
March 05, 2025 08:00 ET | Source: Sernova Biotherapeutics, Inc.

Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing

LONDON, Ontario and BOSTON, March 05, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...